Skip to Content

Cancers, Volume 12, Issue 6

2020 June - 356 articles

Cover Story: Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of kidney cancer and up to 40% of patients submitted to surgery will relapse. Therefore, there is an urgent need to determine prognosis biomarkers. We studied the potential of an extracellular vesicle (EV)-derived microRNA profile as a prognostic biomarker in ccRCC. We focused on plasma EVs from patients with localized (before and after surgery) and metastatic disease. After surgery, EV-derived hsa-miR-301a-3p levels decreased whereas hsa-miR-1293 EV-derived levels increased and those levels remained stable during follow-up. When compared to follow-up patients, metastatic patients presented higher EV-derived hsa-miR-301a-3p and lower hsa-miR-1293. These results suggest that EV content varies depending on the presence or absence of ccRCC and that EV-derived hsa-miR-301a-3p and hsa-miR-1293 may be potential prognostic biomarkers. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (356)

  • Article
  • Open Access
54 Citations
6,039 Views
15 Pages

Association of Allostatic Load with All-Cause and Cancer Mortality by Race and Body Mass Index in the REGARDS Cohort

  • Tomi Akinyemiju,
  • Lauren E Wilson,
  • April Deveaux,
  • Stella Aslibekyan,
  • Mary Cushman,
  • Susan Gilchrist,
  • Monika Safford,
  • Suzanne Judd and
  • Virginia Howard

26 June 2020

Among 29,701 Black and White participants aged 45 years and older in the Reasons for Geographic and Racial Difference in Stroke (REGARDS) study, allostatic load (AL) was defined as the sum score of established baseline risk-associated biomarkers for...

  • Article
  • Open Access
13 Citations
4,447 Views
27 Pages

Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs

  • Michael Seifert,
  • Gabriele Schackert,
  • Achim Temme,
  • Evelin Schröck,
  • Andreas Deutsch and
  • Barbara Klink

26 June 2020

Astrocytomas are primary human brain tumors including diffuse or anaplastic astrocytomas that develop towards secondary glioblastomas over time. However, only little is known about molecular alterations that drive this progression. We measured multi-...

  • Review
  • Open Access
41 Citations
8,386 Views
35 Pages

Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination

  • Angelica Avagliano,
  • Giuseppe Fiume,
  • Maria Rosaria Ruocco,
  • Nunzia Martucci,
  • Eleonora Vecchio,
  • Luigi Insabato,
  • Daniela Russo,
  • Antonello Accurso,
  • Stefania Masone and
  • Alessandro Arcucci
  • + 1 author

26 June 2020

The stromal microenvironment regulates mammary gland development and tumorigenesis. In normal mammary glands, the stromal microenvironment encompasses the ducts and contains fibroblasts, the main regulators of branching morphogenesis. Understanding t...

  • Article
  • Open Access
22 Citations
3,668 Views
19 Pages

The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers

  • Alexander Rühle,
  • Erik Haehl,
  • Hélène David,
  • Tobias Kalckreuth,
  • Tanja Sprave,
  • Raluca Stoian,
  • Constantinos Zamboglou,
  • Eleni Gkika,
  • Andreas Knopf and
  • Nils Henrik Nicolay
  • + 1 author

26 June 2020

The purpose of this study was to evaluate the value of routine blood markers regarding their predictive potential for treatment outcomes of elderly head-and-neck squamous cell carcinoma (HNSCC) patients. In total, 246 elderly HNSCC patients (≥65 y...

  • Review
  • Open Access
41 Citations
7,507 Views
20 Pages

26 June 2020

The field of oncolytic virotherapy has seen remarkable advancements in last two decades, leading to approval of the first oncolytic immuno-virotherapy, Talimogene Laherparepvec, for the treatment of melanoma. A plethora of preclinical and clinical st...

  • Article
  • Open Access
10 Citations
4,384 Views
15 Pages

26 June 2020

Data on the leading shared risk factors of cancer and mental disorders are limited. We included 98,958 participants (54.8% women) aged 45–64 years from the 45 and Up Study who were free of cancer, depression, and anxiety at baseline (2006&ndash...

  • Article
  • Open Access
6 Citations
2,712 Views
14 Pages

Mixed Type Histology as a Predictive Factor for Esophagojejunostomy Leak in Advanced Gastric Cancer

  • Karol Rawicz-Pruszyński,
  • Katarzyna Sędłak,
  • Radosław Mlak,
  • Jerzy Mielko and
  • Wojciech P. Polkowski

26 June 2020

Since esophagojejunostomy leak (EJL) after gastrectomy is a potentially fatal complication and may impact the survival of patients with advanced gastric cancer (GC), it is important to establish risk factors for the EJL and to prevent this surgical c...

  • Article
  • Open Access
33 Citations
4,259 Views
14 Pages

26 June 2020

In addition to their analgesic activity, transient receptor potential vanilloid 1 (TRPV1) agonists and antagonists demonstrate profound anti-cancer activities in various human cancers. In the present study, we investigated the anti-cancer activity of...

  • Article
  • Open Access
16 Citations
6,378 Views
14 Pages

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965

  • Marta Braga,
  • Maciej Kaliszczak,
  • Laurence Carroll,
  • Zachary T. Schug,
  • Kathrin Heinzmann,
  • Nicoleta Baxan,
  • Adrian Benito,
  • Gabriel N. Valbuena,
  • Stephen Stribbling and
  • Eric O. Aboagye
  • + 7 authors

26 June 2020

The monocarboxylate transporter 1 (MCT1) is a key element in tumor cell metabolism and inhibition of MCT1 with AZD3965 is undergoing clinical trials. We aimed to investigate nutrient fluxes associated with MCT1 inhibition by AZD3965 to identify possi...

  • Article
  • Open Access
36 Citations
10,695 Views
16 Pages

26 June 2020

T cells engineered with chimeric antigen receptors (CARs) show great promise in the treatment of some cancers. Modifying T cells to express CARs generally relies on T-cell transduction using viral vectors carrying a transgene, resulting in semi-rando...

  • Article
  • Open Access
3 Citations
4,085 Views
14 Pages

Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer

  • Xuewei Zhang,
  • Masumi Ishibashi,
  • Kazuyuki Kitatani,
  • Shogo Shigeta,
  • Hideki Tokunaga,
  • Masafumi Toyoshima,
  • Muneaki Shimada and
  • Nobuo Yaegashi

26 June 2020

Tyrosine kinase receptor TIE-1 plays a critical role in angiogenesis and blood-vessel stability. In recent years, increased TIE-1 expression has been observed in many types of cancers; however, the biological significance and underlying mechanisms re...

  • Review
  • Open Access
87 Citations
10,615 Views
18 Pages

25 June 2020

Obesity is associated with an increased risk of estrogen receptor-positive breast cancer in postmenopausal women and a worse prognosis for all major breast cancer subtypes regardless of menopausal status. While the link between obesity and the pathog...

  • Review
  • Open Access
23 Citations
6,291 Views
19 Pages

Telomerase and CD4 T Cell Immunity in Cancer

  • Magalie Dosset,
  • Andrea Castro,
  • Hannah Carter and
  • Maurizio Zanetti

25 June 2020

Telomerase reverse transcriptase (TERT) is a conserved self-tumor antigen which is overexpressed in most tumors and plays a critical role in tumor formation and progression. As such, TERT is an antigen of great relevance to develop widely applicable...

  • Review
  • Open Access
19 Citations
10,856 Views
21 Pages

Immunoglobulin M Paraproteinaemias

  • Louis-Pierre Girard,
  • Cinnie Yentia Soekojo,
  • Melissa Ooi,
  • Li Mei Poon,
  • Wee-Joo Chng and
  • Sanjay de Mel

25 June 2020

Monoclonal paraproteinaemia is an increasingly common reason for referral to haematology services. Paraproteinaemias may be associated with life-threatening haematologic malignancies but can also be an incidental finding requiring only observation. I...

  • Article
  • Open Access
18 Citations
3,601 Views
14 Pages

Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric Cancer

  • Bianca Grosser,
  • Meike Kohlruss,
  • Julia Slotta-Huspenina,
  • Moritz Jesinghaus,
  • Nicole Pfarr,
  • Katja Steiger,
  • Alexander Novotny,
  • Matthias M. Gaida,
  • Thomas Schmidt and
  • Gisela Keller
  • + 3 authors

25 June 2020

We investigated the prognostic and predictive impact of p53 expression for gastric cancer (GC) patients treated without or with preoperative chemotherapy (CTx) and its relationship with specific molecular GC subtypes. Specimens from 694 GC patients (...

  • Article
  • Open Access
9 Citations
3,586 Views
10 Pages

Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group

  • Motohiro Murakami,
  • Hitoshi Ishikawa,
  • Shosei Shimizu,
  • Hiromitsu Iwata,
  • Tomoaki Okimoto,
  • Masaru Takagi,
  • Shigeyuki Murayama,
  • Tetsuo Akimoto,
  • Hitoshi Wada and
  • Hideyuki Sakurai
  • + 4 authors

25 June 2020

Background: Androgen deprivation therapy (ADT) combined with radiation therapy benefits intermediate- and high-risk prostate cancer (PC) patients. The optimal ADT duration in combination with high-dose proton beam therapy (PBT) remains unknown. Metho...

  • Article
  • Open Access
14 Citations
3,506 Views
11 Pages

25 June 2020

A randomized clinical trial showed that trastuzumab, added to traditional chemotherapy, significantly improved overall survival in human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic gastric cancer patients. This population-base...

  • Article
  • Open Access
26 Citations
4,885 Views
24 Pages

Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis

  • Matias A. Bustos,
  • Kevin D. Tran,
  • Negin Rahimzadeh,
  • Rebecca Gross,
  • Selena Y. Lin,
  • Yoshiaki Shoji,
  • Tomohiro Murakami,
  • Christine L. Boley,
  • Linh T. Tran and
  • Dave S. B. Hoon
  • + 3 authors

25 June 2020

Primary cutaneous melanoma frequently metastasizes to distant organs including the brain. Identification of cell-free microRNAs (cfmiRs) found in the blood can be used as potential body fluid biomarkers for detecting and monitoring patients with mela...

  • Article
  • Open Access
36 Citations
4,242 Views
19 Pages

Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma

  • Isabelle Flammang,
  • Moritz Reese,
  • Anda J. Ströse,
  • Zixuan Yang,
  • Johannes A. Eble and
  • Sameer A. Dhayat

25 June 2020

Pancreatic ductal adenocarcinoma (PDAC) is characterized by fast tumor progression and diagnosis at advanced, inoperable stages. Previous studies could demonstrate an involvement of miR-192-5p in epigenetic regulation of visceral carcinomas. Due to c...

  • Article
  • Open Access
13 Citations
6,945 Views
19 Pages

Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis

  • Aleksandr Ianevski,
  • Evgeny Kulesskiy,
  • Klara Krpina,
  • Guofeng Lou,
  • Yahyah Aman,
  • Andrii Bugai,
  • Koit Aasumets,
  • Yevhen Akimov,
  • Daria Bulanova and
  • Denis E. Kainov
  • + 17 authors

25 June 2020

Background: The evidence that pan-Bcl-2 or Bcl-xL-specific inhibitors prematurely kill virus-infected or RNA/DNA-transfected cells provides rationale for investigating these apoptotic inducers further. We hypothesized that not only invasive RNA or DN...

  • Article
  • Open Access
43 Citations
5,499 Views
16 Pages

Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress

  • Wangjie Yu,
  • Yunyun Chen,
  • Nagireddy Putluri,
  • Cristian Coarfa,
  • Matthew J. Robertson,
  • Vasanta Putluri,
  • Fabio Stossi,
  • Julien Dubrulle,
  • Michael A. Mancini and
  • Vlad C. Sandulache
  • + 5 authors

24 June 2020

Background: Cisplatin (CDDP) is commonly utilized in the treatment of advanced solid tumors including head and neck squamous cell carcinoma (HNSCC). Cisplatin response remains highly variable among individual tumors and development of cisplatin resis...

  • Article
  • Open Access
116 Citations
6,495 Views
21 Pages

Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation

  • Yasaman Alaghband,
  • Samantha N. Cheeks,
  • Barrett D. Allen,
  • Pierre Montay-Gruel,
  • Ngoc-Lien Doan,
  • Benoit Petit,
  • Patrik Goncalves Jorge,
  • Erich Giedzinski,
  • Munjal M. Acharya and
  • Charles L. Limoli
  • + 1 author

24 June 2020

Major advances in high precision treatment delivery and imaging have greatly improved the tolerance of radiotherapy (RT); however, the selective sparing of normal tissue and the reduction of neurocognitive side effects from radiation-induced toxiciti...

  • Review
  • Open Access
69 Citations
9,673 Views
24 Pages

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

  • Giulia Veronesi,
  • David R. Baldwin,
  • Claudia I. Henschke,
  • Simone Ghislandi,
  • Sergio Iavicoli,
  • Matthijs Oudkerk,
  • Harry J. De Koning,
  • Joseph Shemesh,
  • John K. Field and
  • Giuseppe Pelosi
  • + 27 authors

24 June 2020

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the disease. European mortality data has recently become available from the Nelson randomised c...

  • Review
  • Open Access
19 Citations
5,612 Views
14 Pages

Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review

  • Lianne M. Haveman,
  • Andreas Ranft,
  • Henk van den Berg,
  • Stephanie Klco-Brosius,
  • Ruth Ladenstein,
  • Michael Paulussen,
  • Heribert Juergens,
  • Uta Dirksen and
  • Johannes H.M. Merks

24 June 2020

Intracranial Ewing sarcoma (EwS) is rare and publications on primary or metastatic intracranial EwS are minimal. The aim of this study was to describe incidence, clinical behavior, treatment, and factors associated with outcome in patients with prima...

  • Article
  • Open Access
17 Citations
4,951 Views
24 Pages

Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib

  • Sergei Boichuk,
  • Aigul Galembikova,
  • Ekaterina Mikheeva,
  • Firuza Bikinieva,
  • Aida Aukhadieva,
  • Pavel Dunaev,
  • Dinar Khalikov,
  • Semen Petrov,
  • Refat Kurtasanov and
  • Pavel Kopnin
  • + 5 authors

24 June 2020

Inhibition of KIT-signaling is a major molecular target for gastrointestinal stromal tumor (GIST) therapy, and imatinib mesylate (IM) is known as the most effective first-line treatment option for patients with advanced, unresectable, and/or metastat...

  • Article
  • Open Access
7 Citations
3,895 Views
10 Pages

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis

  • Panagiotis Karagiannis,
  • Lena Sänger,
  • Winfried Alsdorf,
  • Katja Weisel,
  • Walter Fiedler,
  • Stefan Kluge,
  • Dominic Wichmann,
  • Carsten Bokemeyer and
  • Valentin Fuhrmann

24 June 2020

High dose chemotherapy (HDT) followed by autologous peripheral blood stem cell transplantation (ASCT) is standard of care including a curative treatment option for several cancers. While much is known about the management of patients with allogenic S...

  • Article
  • Open Access
19 Citations
4,771 Views
13 Pages

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis

  • Reza Elaidi,
  • Letuan Phan,
  • Delphine Borchiellini,
  • Philippe Barthelemy,
  • Alain Ravaud,
  • Stéphane Oudard and
  • Yann Vano

24 June 2020

Three drug combinations, ipilimumab-nivolumab (Ipi-Nivo), pembrolizumab-axitinib (Pembro-Axi), and avelumab-axitinib (Ave-Axi), have received regulatory approval in the USA and Europe for the treatment of metastatic renal cell carcinoma with clear ce...

  • Review
  • Open Access
11 Citations
4,542 Views
24 Pages

The Double-Edged Sword Role of Viruses in Gastric Cancer

  • Paulina Niedźwiedzka-Rystwej,
  • Ewelina Grywalska,
  • Rafał Hrynkiewicz,
  • Mikołaj Wołącewicz,
  • Rafał Becht and
  • Jacek Roliński

24 June 2020

Due to its high morbidity and mortality, gastric cancer is a topic of a great concern throughout the world. Major ways of treatment are gastrectomy and chemotherapy, unfortunately they are not always successful. In a search for more efficient therapy...

  • Review
  • Open Access
16 Citations
4,869 Views
17 Pages

24 June 2020

Telomerase reverse transcriptase (TERT)—the catalytic subunit of telomerase—is reactivated in up to 90% of all human cancers. TERT is observed in heterogenous populations of protein complexes, which are dynamically regulated in a cell typ...

  • Review
  • Open Access
26 Citations
4,501 Views
28 Pages

Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)

  • Nicola Silvestris,
  • Oronzo Brunetti,
  • Alessandro Bittoni,
  • Ivana Cataldo,
  • Domenico Corsi,
  • Stefano Crippa,
  • Mirko D’Onofrio,
  • Michele Fiore,
  • Elisa Giommoni and
  • Michele Reni
  • + 3 authors

24 June 2020

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5% at 5 years. From 2010, the Italian Association of Medical Oncology (AIOM...

  • Opinion
  • Open Access
64 Citations
12,614 Views
17 Pages

Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy

  • Kosuke Murakami,
  • Yasushi Kotani,
  • Hidekatsu Nakai and
  • Noriomi Matsumura

24 June 2020

Endometrial cysts (ECs) are thought to be the origin of endometriosis-associated ovarian cancer (EAOC). A hypothesis that the oxidative stress of iron in cysts causes “malignant transformation of ECs” has been proposed, but this has not b...

  • Review
  • Open Access
47 Citations
7,298 Views
24 Pages

Integrating the Tumor Microenvironment into Cancer Therapy

  • Sabina Sanegre,
  • Federico Lucantoni,
  • Rebeca Burgos-Panadero,
  • Luis de La Cruz-Merino,
  • Rosa Noguera and
  • Tomás Álvaro Naranjo

24 June 2020

Tumor progression is mediated by reciprocal interaction between tumor cells and their surrounding tumor microenvironment (TME), which among other factors encompasses the extracellular milieu, immune cells, fibroblasts, and the vascular system. Howeve...

  • Article
  • Open Access
51 Citations
6,714 Views
20 Pages

Multiparametric Analysis of Longitudinal Quantitative MRI Data to Identify Distinct Tumor Habitats in Preclinical Models of Breast Cancer

  • Anum K. Syed,
  • Jennifer G. Whisenant,
  • Stephanie L. Barnes,
  • Anna G. Sorace and
  • Thomas E. Yankeelov

24 June 2020

This study identifies physiological tumor habitats from quantitative magnetic resonance imaging (MRI) data and evaluates their alterations in response to therapy. Two models of breast cancer (BT-474 and MDA-MB-231) were imaged longitudinally with dif...

  • Article
  • Open Access
7 Citations
5,452 Views
12 Pages

Role of Colposcopy after Treatment for Cervical Intraepithelial Neoplasia

  • Annu Heinonen,
  • Maija Jakobsson,
  • Mari Kiviharju,
  • Seppo Virtanen,
  • Karoliina Aro,
  • Maria Kyrgiou,
  • Pekka Nieminen and
  • Ilkka Kalliala

24 June 2020

Colposcopy is often used in follow-up after treatment for cervical intraepithelial neoplasia (CIN) despite its marked inter-observer variability and low sensitivity. Our objective was to assess the role of colposcopy in post-treatment follow-up in co...

  • Article
  • Open Access
9 Citations
5,498 Views
14 Pages

Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer

  • Stefanie Schatz,
  • Markus Falk,
  • Balázs Jóri,
  • Hayat O. Ramdani,
  • Stefanie Schmidt,
  • Eva-Maria Willing,
  • Roopika Menon,
  • Harry J. M. Groen,
  • Linda Diehl and
  • Lukas C. Heukamp
  • + 5 authors

24 June 2020

In recent years, Non-small cell lung cancer (NSCLC) has evolved into a prime example for precision oncology with multiple FDA-approved “precision” drugs. For the majority of NSCLC lacking targetable genetic alterations, immune checkpoint...

  • Article
  • Open Access
32 Citations
6,045 Views
18 Pages

A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning

  • Valentina Gaidano,
  • Valerio Tenace,
  • Nathalie Santoro,
  • Silvia Varvello,
  • Alessandro Cignetti,
  • Giuseppina Prato,
  • Giuseppe Saglio,
  • Giovanni De Rosa and
  • Massimo Geuna

24 June 2020

The immunophenotype is a key element to classify B-cell Non-Hodgkin Lymphomas (B-NHL); while it is routinely obtained through immunohistochemistry, the use of flow cytometry (FC) could bear several advantages. However, few FC laboratories can rely on...

  • Article
  • Open Access
47 Citations
4,659 Views
12 Pages

23 June 2020

The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducin...

  • Review
  • Open Access
51 Citations
11,690 Views
28 Pages

Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process

  • Sara Feola,
  • Jacopo Chiaro,
  • Beatriz Martins and
  • Vincenzo Cerullo

23 June 2020

According to the latest available data, cancer is the second leading cause of death, highlighting the need for novel cancer therapeutic approaches. In this context, immunotherapy is emerging as a reliable first-line treatment for many cancers, partic...

  • Review
  • Open Access
24 Citations
5,543 Views
22 Pages

Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging

  • Luiza Steffens Reinhardt,
  • Xiajie Zhang,
  • Anna Wawruszak,
  • Kira Groen,
  • Geoffry N. De Iuliis and
  • Kelly A. Avery-Kiejda

23 June 2020

The tumour suppressor p53 is essential for maintaining DNA integrity, and plays a major role in cellular senescence and aging. Understanding the mechanisms that contribute to p53 dysfunction can uncover novel possibilities for improving cancer therap...

  • Article
  • Open Access
27 Citations
4,676 Views
14 Pages

23 June 2020

B-Rapidly Accelerated Fibrosarcoma (BRAF) mutations are found in about 50% of melanoma patients. Treatment with Food and Drug Administration (FDA)-approved BRAF and MAP/ERK kinase (MEK) inhibitors has improved progression free and overall survival of...

  • Review
  • Open Access
62 Citations
7,114 Views
27 Pages

Non-Coding RNAs in Cancer Radiosensitivity: MicroRNAs and lncRNAs as Regulators of Radiation-Induced Signaling Pathways

  • Marta Podralska,
  • Sylwia Ciesielska,
  • Joost Kluiver,
  • Anke van den Berg,
  • Agnieszka Dzikiewicz-Krawczyk and
  • Izabella Slezak-Prochazka

23 June 2020

Radiotherapy is a cancer treatment that applies high doses of ionizing radiation to induce cell death, mainly by triggering DNA double-strand breaks. The outcome of radiotherapy greatly depends on radiosensitivity of cancer cells, which is determined...

  • Review
  • Open Access
137 Citations
9,433 Views
26 Pages

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

  • Jose J.G. Marin,
  • Rocio I.R. Macias,
  • Maria J. Monte,
  • Marta R. Romero,
  • Maitane Asensio,
  • Anabel Sanchez-Martin,
  • Candela Cives-Losada,
  • Alvaro G. Temprano,
  • Ricardo Espinosa-Escudero and
  • Oscar Briz
  • + 2 authors

23 June 2020

The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pha...

  • Review
  • Open Access
119 Citations
8,424 Views
28 Pages

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy

  • Flávia Alves Verza,
  • Umashankar Das,
  • Ana Lúcia Fachin,
  • Jonathan R. Dimmock and
  • Mozart Marins

23 June 2020

Histones are the main structural proteins of eukaryotic chromatin. Histone acetylation/ deacetylation are the epigenetic mechanisms of the regulation of gene expression and are catalyzed by histone acetyltransferases (HAT) and histone deacetylases (H...

  • Article
  • Open Access
21 Citations
4,249 Views
11 Pages

Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study

  • Sandra Huynh,
  • Laurent Mortier,
  • Caroline Dutriaux,
  • Eve Maubec,
  • Marie Boileau,
  • Olivier Dereure,
  • Marie-Therese Leccia,
  • Jean-Philippe Arnault,
  • Florence Brunet-Possenti and
  • Julie Delyon
  • + 5 authors

23 June 2020

Despite significant progress in melanoma survival, therapeutic options are still needed in case of progression under immune checkpoint inhibitors (ICI), and resistance to targeted therapies (TT) in BRAF-mutated melanomas. This study aimed to assess t...

  • Review
  • Open Access
37 Citations
9,459 Views
22 Pages

Klotho and the Treatment of Human Malignancies

  • Aishani Sachdeva,
  • Jerome Gouge,
  • Christos Kontovounisios,
  • Stella Nikolaou,
  • Alan Ashworth,
  • Kenneth Lim and
  • Irene Chong

23 June 2020

Klotho was first discovered as an anti-ageing protein linked to a number of age-related disease processes, including cardiovascular, renal, musculoskeletal, and neurodegenerative conditions. Emerging research has also demonstrated a potential therape...

  • Review
  • Open Access
76 Citations
8,564 Views
30 Pages

23 June 2020

Hepatocellular carcinoma (HCC) metabolism is redirected to glycolysis to enhance the production of metabolic compounds employed by cancer cells to produce proteins, lipids, and nucleotides in order to maintain a high proliferative rate. This mechanis...

  • Article
  • Open Access
17 Citations
3,480 Views
15 Pages

Rac1 Promotes Cell Motility by Controlling Cell Mechanics in Human Glioblastoma

  • Jing Xu,
  • Nicola Galvanetto,
  • Jihua Nie,
  • Yili Yang and
  • Vincent Torre

23 June 2020

The failure of existing therapies in treating human glioblastoma (GBM) mostly is due to the ability of GBM to infiltrate into healthy regions of the brain; however, the relationship between cell motility and cell mechanics is not well understood. Her...

  • Article
  • Open Access
6 Citations
4,489 Views
17 Pages

Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma

  • Jiwon Koh,
  • Insoon Jang,
  • Seongmin Choi,
  • Sehui Kim,
  • Ingeon Jang,
  • Hyun Kyung Ahn,
  • Cheol Lee,
  • Jin Ho Paik,
  • Chul Woo Kim and
  • Yoon Kyung Jeon
  • + 2 authors

23 June 2020

Nodal marginal zone lymphoma (NMZL) is a rare B-cell neoplasm, the genetic and transcriptomic landscape of which are unclear. Using high-throughput sequencing for whole-exome and transcriptome, we investigated the genetic characteristics of NMZL in a...

  • Article
  • Open Access
25 Citations
4,479 Views
23 Pages

COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma

  • Yu-De Chu,
  • Wey-Ran Lin,
  • Yang-Hsiang Lin,
  • Wen-Hsin Kuo,
  • Chin-Ju Tseng,
  • Siew-Na Lim,
  • Yen-Lin Huang,
  • Shih-Chiang Huang,
  • Ting-Jung Wu and
  • Chau-Ting Yeh
  • + 1 author

22 June 2020

The oxidative phosphorylation machinery in mitochondria, which generates the main bioenergy pool in cells, includes four enzyme complexes for electron transport and ATP synthase. Among them, the cytochrome c oxidase (COX), which constitutes the fourt...

  • Feature Paper
  • Review
  • Open Access
84 Citations
8,795 Views
17 Pages

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer

  • Simon P. Langdon,
  • C. Simon Herrington,
  • Robert L. Hollis and
  • Charlie Gourley

22 June 2020

The estrogen receptor (ER) has functionality in selected ovarian cancer subtypes and represents a potential target for therapy. The majority (>80%) of high grade serous, low grade serous and endometrioid carcinomas and many granulosa cell tumors e...

of 8

XFacebookLinkedIn
Cancers - ISSN 2072-6694